Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial

Reporter: Annemarie Fernandes, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 2 de junio del 2012

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Unplanned Hospitalizations With GI Cancer Patients Common

Oct 22, 2014

Top reasons include electrolyte disorders, intestinal obstruction, pneumonia

One-Fifth of Hospitalizations in Advanced GI Cancer Avoidable

Jan 20, 2014

Higher 90-day mortality seen after avoidable versus non-avoidable hospitalizations

BMP Use in Spinal Arthrodesis Doesn't Up Cancer Risk

Oct 7, 2014

No increased invasive cancer risk from bone morphogenetic protein exposure in men or women

Frequently Asked Questions